Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Hagens Berman / ImmunityBio

Hagens Berman & ImmunityBio

2 shared events · Importance 4 · Last updated May 06, 2026

Importance
4
Shared Events
2
Actions
1
Sentiment
5.0
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (2)
84
Regulatory
ImmunityBio Faces Anktiva Misleading Claims Lawsuit
Hagens Berman: Hagens Berman is a national shareholders rights firm investigating claims that ImmunityBio violated federal securities laws and is urging investors to submit their losses.
ImmunityBio: ImmunityBio is facing a securities class action lawsuit for allegedly making misleading claims about its product Anktiva, which caused its stock price to drop and market capitalization to decrease by nearly $2 billion.
Apr 02, 2026 · 42 articles
0
Regulatory
ImmunityBio Faces Securities Class Actions
Apr 01, 2026 · 45 articles
Actions (1)
75 Hagens Berman investigated claims ImmunityBioImmunityBio Faces Anktiva...
NEWSDESK
Explore this relationship live

Track how Hagens Berman and ImmunityBio interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.